Neuroinflammation In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
Neuroinflammation is a central pathological feature of virtually all neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and multiple sclerosis (MS). It involves the activation of glial cells—primarily microglia and astrocytes—and the release of pro-inflammatory cytokines, chemokines, and reactive oxygen/nitrogen species. While acute neuroinflammation serves protective functions, chronic neuroinflammation becomes deleterious and drives disease progression.
Microglia are the resident immune cells of the central nervous system, derived from yolk sac progenitors. In the healthy brain, they survey the environment and maintain homeostasis. Upon activation, microglia undergo morphological and functional changes, transitioning between different phenotypes:
Astrocytes respond to neuroinflammation by becoming reactive, upregulating glial fibrillary acidic protein (GFAP), and releasing inflammatory mediators. Reactive astrocytes can adopt either neuroprotective (A2) or neurotoxic (A1) phenotypes:
Nuclear factor kappa B (NF-kB) is a master regulator of neuroinflammation. Activated by:
NF-kB translocates to the nucleus and induces transcription of:
The NLRP3 inflammasome is a cytosolic protein complex that activates caspase-1, leading to maturation of pro-inflammatory cytokines:
The complement cascade contributes to neuroinflammation through:
| Target | Approach | Examples |
|---|---|---|
| NLRP3 inhibitors | Block inflammasome activation | MCC950, Dapansutrile |
| TGF-beta signaling | Promote A2 phenotype | BMP7, SMAD7 |
| TREM2 activation | Enhance phagocytosis | Anti-TREM2 antibodies |
| COX-2 inhibitors | Reduce prostaglandin synthesis | Celecoxib |
| Minocycline | Broad microglial modulation | Tetracycline antibiotic |
The study of Neuroinflammation In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 8 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 29%